| abstract |
A solid oral dosage form comprising bromocriptine and one or more pharmaceutically acceptable excipients is described herein. The oral dosage form has a dissolution rate greater than 90% in 5 min in 500 ml of 0.1N HC1 aqueous medium at 37 degree C, and is useful for adjusting the prolactin profile of a patient's plasma. |